Singapore Biomedical News   EDB reports an outstanding year of growth and quality investments in 2007>     Portfolio Company News   A-Bio Pharma Pte Ltd 17 Sep, 2007 Artisan, Singapore's A-Bio Join Forces On Recombinant Sepsis Candidate     Alexza Pharmaceuticals, Inc. 28 Mar, 2008 Bio*One takes US$10m stake in Nasdaq firm     Artisan Pharma Inc 17 Sep, 2007 Artisan, Singapore's A-Bio Join Forces On Recombinant Sepsis Candidate     Dx Assays Pte Ltd 09 Sep, 2008 Singapore's first Commercial Developer of Molecular Diagnostic Assays commences operations 03 Dec, 2007 QIAGEN and Bio*One Capital Enter into Joint Venture to Develop Molecular Diagnostics Products     ES Cell International Pte Ltd 09 Sep, 2008 ES Cell International Announces Partnership with Large Pharma for assessment of GMP-Grade Stem Cell Lines 09 Sep, 2008 Human Stem Cell help mice in MS Research 09 Oct, 2007 $1.5m boost for stem cell firm's subsidiary 09 Oct, 2007 Stem cell firm lands US$1m investment     Merlion Pharmaceuticals Pte Ltd 06 Dec, 2007 MerLion Pharmaceuticals Wins Prestigious Pharmaceutical Industry Scrip Award     S*BIO Pte Ltd 18 Sep, 2008 S*BIO Initiates U.S. Phase I Clinical Trials of Oral JAK2 Inhibitor SB1518 for the Treatment of Hematological Malignancies     Spine Vision SA 28 Nov, 2007 SpineVision’s product PediGuard? was conferred the prestigious Singapore     U3 Pharma AG 21 May, 2008 Daiichi Sankyo Co Ltd. to buy U3 Pharma for US$234M (150M Euros)     Vanda Pharmaceuticals Inc. 27 Nov, 2007 Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application